engineered autologous T cells
09-036
Phase 1 mab active
Quick answer
engineered autologous T cells for Prostate Cancer is a Phase 1 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Prostate Cancer
- Phase
- Phase 1
- Modality
- mab
- Status
- active